Medicare Enrolled

Dr. Vasiliki Dimas, MD

Pediatric Critical Care · Dallas, TX
Consulting-driven
5323 HARRY HINES BLVD, Dallas, TX 75390
2147305437
In practice since 2006 (19 years)
NPI: 1639102148 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dimas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dimas? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Dimas

Dr. Vasiliki Dimas is a pediatric critical care in Dallas, TX, with 19 years in practice.

Between the years covered by Open Payments, Dr. Dimas received a total of $346,096 from 15 pharmaceutical and/or device companies across 494 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pediatric critical care. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Dimas is High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice$ $346,096 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$346,096
Total received (2018-2024)
Avg $49,442/year across 7 years
Top 1% in TX for pediatric critical care
15
Companies
494
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$236,862 (68.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$69,955 (20.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$39,279 (11.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$65,309
2023
$120,016
2022
$100,904
2021
$11,878
2020
$1,081
2019
$25,089
2018
$21,820

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Edwards Lifesciences Corporation
$223,977
Medtronic, Inc.
$49,899
Medtronic Vascular, Inc.
$23,852
B. Braun Interventional Systems Inc.
$23,716
ABIOMED
$14,402
Abbott Laboratories
$6,890
Boston Scientific Corporation
$1,305
Galt Medical
$879
BOSTON SCIENTIFIC CORPORATION
$745
W. L. Gore & Associates, Inc.
$136
HeartFlow, Inc.
$121
Biosense Webster, Inc.
$83
GE HEALTHCARE
$49
Cook Medical LLC
$29
Cardiac Assist, Inc.
$11
Top 3 companies account for 86.0% of total payments
Associated products mentioned in payments ›
ABRE · ABSORB · ACUITY Steerable · AMPLATZER · AMPLATZER AMULET · AMPLATZER Occluders · AMPLATZER PICCOLO · Azure · BodyGuardian · CARDIOFORM Septal Occluder · CONCERTOTM · COOK MEDICAL BALLOON-EXPANDING STENT · COREVALVE EVOLUT R · CP STENT · CP STENT TRANSCATHETER STENT · Cardiovascular-Research only · CareLink · Claria MRI · CoreValve Evolut · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · EMBLEM MRI S-ICD · EMBLEM SICD ELECTRODE DELIVERY SYSTEM · ENSITE · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Edwards SAPIEN XT Transcatheter Heart Valve · GENERAL THERAPIES · GENERAL TACHY · GENERAL THERAPIES · GENERAL - THERAPIES · GENERAL TACHY · GENERAL THERAPIES · General - Therapies · HARMONY · Harmony · Impella · LATITUDE Communicator Power Supply · LUX-Dx Insertable Cardiac Monitor · MELODY TPV · MVP · Melody · Micra · NA · NIT-OCCLUD HEART CLOSURE DEVICE · NIT-OCCLUD PDA · NO MARKETED PRODUCT NAME · ONO RETRIEVAL DEVICE · Perclose ProGlide suture mediated closure system · RESONATE EL ICD VR · Supera peripheral stent system · THE EDWARDS SAPIEN 3 VALVE WITH ALTERRA ADAPTIVE PRESTENT SYSTEM · TandemHeart · ViewMate Intracardiac Echo · WATCHMAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (68%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 1% for pediatric critical care in TX.

Looking for a pediatric critical care in Dallas?
Compare pediatric critical cares in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse pediatric critical cares nearby

Geographic Context

Pediatric Critical Cares within 10 mi
53
Per 100K population
2.0
County median income
$74,149
Nearest hospital
UT OF TEXAS SOUTHWESTERN UNIVERSITY HOSPITAL - WILLIAM P. CLEMENTS JR.
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Dimas is a pediatric critical care, and high industry engagement (consulting-driven, top 1%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Dimas receive payments from pharmaceutical companies?
Yes. Dr. Dimas received a total of $346,096 from 15 companies across 494 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Dimas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →